PIK3CA and cancer: The presented mechanistic study provides a rationale for dual targeting of MEK and PI3K as an efficient approach to block YB-1 phosphorylation at S102 and hamper its functions in cancer cells, such as resisting cell death and stimulating cell proliferation.